2022
DOI: 10.3389/fgene.2022.799970
|View full text |Cite
|
Sign up to set email alerts
|

Drug Discovery in Spinal Cord Injury With Ankylosing Spondylitis Identified by Text Mining and Biomedical Databases

Abstract: Spinal cord injury (SCI) and ankylosing spondylitis (AS) are common inflammatory diseases in spine surgery. However, it is a project where the relationship between the two diseases is ambiguous and the efficiency of drug discovery is limited. Therefore, the study aimed to investigate new drug therapies for SCI and AS. First, text mining was used to obtain the interacting genes related to SCI and AS, and then, the functional analysis was conducted. Protein–protein interaction (PPI) networks were constructed by … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 42 publications
1
1
0
Order By: Relevance
“…PROS1 expression is positively correlated with neutrophil count and activity and oxidative burst, and is a potential therapeutic target for decompensated cirrhosis and sepsis [44]. PROS1 can be used as a targeted drug for the treatment of in ammatory diseases, such as spinal cord injury and ankylosing spondylitis [45]. In the present study, PROS1 expression was upregulated in the NS group.…”
Section: Signi Cance Of Gene Expression Signatures In Ns Diagnosissupporting
confidence: 55%
“…PROS1 expression is positively correlated with neutrophil count and activity and oxidative burst, and is a potential therapeutic target for decompensated cirrhosis and sepsis [44]. PROS1 can be used as a targeted drug for the treatment of in ammatory diseases, such as spinal cord injury and ankylosing spondylitis [45]. In the present study, PROS1 expression was upregulated in the NS group.…”
Section: Signi Cance Of Gene Expression Signatures In Ns Diagnosissupporting
confidence: 55%
“…PROS1 expression is positively correlated with neutrophil count and activity and oxidative burst, and is a potential therapeutic target for decompensated cirrhosis and sepsis [ 46 ]. PROS1 can be used as a targeted drug for the treatment of inflammatory diseases, such as spinal cord injury and ankylosing spondylitis [ 47 ]. In the present study, PROS1 expression was up-regulated in the NS group.…”
Section: Discussionmentioning
confidence: 99%